会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 42. 发明申请
    • AUDIO TESTING SYSTEM AND METHOD
    • 音频测试系统和方法
    • US20120155660A1
    • 2012-06-21
    • US13012822
    • 2011-01-25
    • YU-KAI XIONGXIN LUSHIH-FANG WONGDONG-SHENG LVZHENG-FEI WANGXIN-HUA LI
    • YU-KAI XIONGXIN LUSHIH-FANG WONGDONG-SHENG LVZHENG-FEI WANGXIN-HUA LI
    • H04R29/00
    • G10L25/45G10L25/69
    • An audio testing system includes an acquisition unit, an input unit, a first analysis unit, a second analysis unit, and an output unit. The acquisition unit obtains an audio signal played back by the audio player. The input unit generates a first input signal and a second input signal. The first analysis unit analyzes the acquired audio signal with a first analysis method in response to the first input signal to obtain performance parameters of the audio player. The second analysis unit analyzes the acquired audio signal with a second analysis method in response to the second input signal to obtain another set of performance parameters of the audio player. The first analysis unit is more accurate than the second analysis unit, and efficiency of the second analysis unit exceeds that of the first analysis unit.
    • 音频测试系统包括采集单元,输入单元,第一分析单元,第二分析单元和输出单元。 获取单元获得由音频播放器播放的音频信号。 输入单元产生第一输入信号和第二输入信号。 第一分析单元响应于第一输入信号利用第一分析方法分析所获取的音频信号,以获得音频播放器的性能参数。 第二分析单元响应于第二输入信号用第二分析方法分析所获取的音频信号,以获得音频播放器的另一组性能参数。 第一分析单元比第二分析单元更精确,第二分析单元的效率超过第一分析单元的效率。
    • 46. 发明授权
    • Fan speed control system
    • 风机转速控制系统
    • US08093854B2
    • 2012-01-10
    • US12246209
    • 2008-10-06
    • Fei Wang
    • Fei Wang
    • G05B11/28
    • G06F1/206Y02D10/16
    • A system for controlling the fan speed is described. Specifically, one embodiment of the present invention set forth a computing system, which includes a first processing unit including a first sensor, wherein the first processing unit is configured to generate a first pulse-width modulation signal, and a first transmission line further including a first direct current voltage converter configured to convert the first pulse-width modulation signal to a first direct current voltage and a first diode coupled to the first direct current voltage converter, wherein the first diode determines whether the first direct current voltage passes through the first diode. The computing system further includes an amplifier coupled to the first diode, wherein the amplifier is configured to amplify a selected direct current voltage to drive a fan.
    • 描述用于控制风扇速度的系统。 具体地,本发明的一个实施例提出了一种计算系统,其包括:第一处理单元,包括第一传感器,其中第一处理单元被配置为产生第一脉冲宽度调制信号;以及第一传输线, 第一直流电压转换器,被配置为将第一脉冲宽度调制信号转换为第一直流电压,以及耦合到第一直流电压转换器的第一二极管,其中第一二极管确定第一直流电压是否通过第一二极管 。 所述计算系统还包括耦合到所述第一二极管的放大器,其中所述放大器被配置为放大所选择的直流电压以驱动风扇。
    • 50. 发明申请
    • MIR 204, MIR 211, THEIR ANTI-MIRS, AND THERAPEUTIC USES OF SAME
    • MIR 204,MIR 211,它们的防乳剂,以及同样的治疗用途
    • US20110190378A1
    • 2011-08-04
    • US13060877
    • 2009-08-26
    • Fei WangSheldon Miller
    • Fei WangSheldon Miller
    • A61K31/711A61P27/02A61P27/10
    • A61K31/7105C12N15/1138C12N2310/113C12N2310/14C12N2310/141
    • Embodiments of the invention provide methods of preventing or treating detrimental epithelial cell proliferation, loss of epithelial cell differentiation, age-related macular degeneration and/or proliferative vitreal retinopathy in an individual comprising administering to an individual in need thereof an effective amount of miR 204, an effective amount of miR 211, or an effective amount of a mixture of miR 204 and miR 211. A further embodiment of the invention provides a method of facilitating the transport of a substance across an epithelium in an individual comprising administrating to an individual an effective amount of anti-miR 204, an effective amount of anti-miR 211, or an effective amount of a mixture of anti-miR 204 and anti-miR 211. Additional embodiments of the invention include pharmaceutical compositions of miR 204 and/or miR 211 and pharmaceutical compositions of anti-miR 204 and/or anti-miR 211.
    • 本发明的实施方案提供预防或治疗个体中有害上皮细胞增殖,上皮细胞分化丧失,年龄相关性黄斑变性和/或增殖性玻璃体视网膜病变的方法,包括向有需要的个体施用有效量的miR 204, 有效量的miR 211或有效量的miR 204和miR 211的混合物。本发明的另一个实施方案提供了促进物质通过个体上皮的运输的方法,包括向个体施用有效量的miR 抗miR204的量,有效量的抗miR 211,或有效量的抗miR 204和抗miR 211的混合物。本发明的其它实施方案包括miR 204和/或miR 211的药物组合物 和抗miR 204和/或抗miR 211的药物组合物。